Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05277844 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC

Study acronym: TARGET-01
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Nov 11, 2023 to Nov 11, 2026 Completion date: Nov 11, 2025 to Nov 11, 2027v3 Show 1 more changeShow less
    • Completion date: Nov 11, 2025 to Nov 11, 2027
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Phase II randomized controlled trial of TKI Alone versus TKI and Local Consolidative Radiation Therapy in oncogene driver mutated oligo metastatic Non-small cell lung cancer patients.
Trial Details
NCT Number NCT05277844
Lead Sponsor Tata Memorial Hospital
Conditions Oligometastatic Disease, Non-small Cell Lung Cancer, Driver Mutation
Enrollment 106 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov